Last Posted: Mar 11, 2020
- Assessment of Biomarker Testing for Lung Cancer Screening Eligibility.
Larose Tricia L et al. JAMA network open 2020 Mar 3(3) e200409 - Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics.
Dragani Tommaso A et al. BioEssays : news and reviews in molecular, cellular and developmental biology 2020 Mar e1900122 - What Is Colorectal Cancer Screening?
CDC, March 2020 - Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives.
Esquivel-Sada Daphne et al. Healthcare policy = Politiques de sante 2019 Nov 15(2) 39-54 - Mammographic screening in male patients at high risk for breast cancer: is it worth it?
Marino Maria Adele et al. Breast cancer research and treatment 2019 Oct 177(3) 705-711 - Should polygenic risk scores be used in risk-stratified colorectal cancer screening?
WD Dotson et al, CDC Blog Post, February 24, 2020 - Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults.
Weiser Emily et al. Journal of medical screening 2020 Feb 969141320903756 - A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
Cortesi Laura et al. Cancer medicine 2020 Feb - Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
Guibert Nicolas et al. European respiratory review : an official journal of the European Respiratory Society 2020 Mar 29(155) - Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single-arm trial of personalized risk communication.
Xie Zhuoer et al. Psycho-oncology 2019 28(11) 2226-2232
.png)
No hay comentarios:
Publicar un comentario